Hadassah

Study by Renowned Hadassah Neuropsychiatrist Featured in The Lancet

Thursday, Sep 7 2017

The work of Dr. Shahar Arzy, head of the Hadassah Medical Organization’s Neuropsychiatry Clinic and the Hadassah-Hebrew University Computational Neuropsychiatry Laboratory, is featured in the September 4, 2017 issue of The Lancet Psychiatry.

Dr. Arzy’s study, in collaboration with colleagues in Berlin, Germany, involved 43 patients with a particular form of severe brain inflammation. Using functional magnetic resonance imaging (MRI), the research team was able to witness changes in the connections within the patients’ brain networks.

Individuals who suffer from this particular form of brain inflammation called “anti-NMDA receptor encephalitis,” exhibit severe neuropsychiatric symptoms, including psychosis, memory deficits, and movement disorders. How the specific dysfunction leads to these clinical symptoms, however, is not understood. Do the symptoms arise from an impairment in specific brain regions? Do they arise from the interactions between these impaired regions?  The answers remain elusive.

In this study, Dr. Arzy’s research team observed 43 age and sex-matched healthy individuals, along with the 43 who had encephalitis. Although structural MRI proved normal in 31 (72 percent) of the 43 patients, the researchers report that they observed “widespread alterations of functional connectivity” and that these alterations correlated with what they saw clinically. The authors explain that “memory impairment correlated with hippocampal and medial-temporal-lobe network connectivity, whereas schizophrenia-like symptoms were associated with functional connectivity changes in frontoparietal networks.”

As the authors summarize: “This study reveals a characteristic pattern of whole-brain functional connectivity alterations in anti-NMDAR encephalitis that is well suited to explain the major clinical symptoms of the disorder.”  They also note that their findings could be similarly relevant for other neuropsychiatric disorders, such as schizophrenia.

Comments

No comments yet.
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Wednesday, Feb 14 2018

Student with MS Running the Jerusalem Marathon to Support Hadassah’s MS Program

Thanks to his physicians at the Hadassah Medical Center, Dov Guggenheim, who was diagnosed with Multiple Sclerosis (MS) in 2015, has gone from “depressed to optimistic, paralyzed to athletic, and, most important, hopeless to hopeful.”

READ MORE ›
alt_text

Wednesday, Feb 7 2018

Texas Tropical Disease Expert Meets with Hadassah Infectious Disease Specialists

Dr. Peter Jay Hotez, renowned professor in the Departments of Pediatrics and Molecular Virology and Microbiology at Houston (Texas) Baylor College of Medicine and Dean of its National School of Tropical Medicine, met with two Hadassah Medical Organization infectious disease specialists to discuss regional cooperation in fighting tropical diseases, such as the now-infamous Zika virus and leishmaniosis, which is contracted from sand flies.

READ MORE ›
alt_text

Wednesday, Feb 7 2018

Large Hadassah Study Identifies Predictor of Greater Risk of End-Stage Renal Disease

The findings of a nationwide study of over a million and a half Israeli adolescents, conducted by researchers at the Hadassah-Hebrew University Braun School of Public Health and Community Medicine, suggest that kidney disease in childhood is associated with a significantly increased risk of end-stage renal disease (ESRD) in adulthood, even if kidney function seems normal in adolescence.

READ MORE ›
alt_text

Wednesday, Feb 7 2018

Israeli Start-up’s Algorithm Predicts Which Diabetic Patients Will Suffer Kidney Dysfunction Within One Year

The Israeli start-up Medial EarlySign has created a machine-learning-based model that has proven to identify diabetic patients who are at the highest risk for experiencing renal dysfunction within one year.

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Missions Department

missions@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More